The 5th edition of the 2021 World Health Organization (WHO) classification of thoracic tumors defines thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) as a new entity of rare malignant tumor with an aggressive clinical course (Nicholson et al., 2021). Here, SMARCA4 is linked to cancer.